financetom
Business
financetom
/
Business
/
BRIEF-CyberArk Shareholders Approve The Company's Acquisition By Palo Alto Networks
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-CyberArk Shareholders Approve The Company's Acquisition By Palo Alto Networks
Nov 13, 2025 1:44 PM

Nov 13 (Reuters) - Cyberark Software Ltd:

* CYBERARK SHAREHOLDERS APPROVE THE COMPANY'S ACQUISITION BY

PALO

ALTO NETWORKS

* CYBERARK SOFTWARE LTD - DEAL EXPECTED TO CLOSE IN SECOND

HALF OF

PANW'S FISCAL YEAR 2026

Source text:

Further company coverage:

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Form 8.3
Form 8.3
Mar 11, 2026
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of...
Disney sends cease-and-desist to ByteDance over AI-generated videos
Disney sends cease-and-desist to ByteDance over AI-generated videos
Mar 11, 2026
Feb 15 (Reuters) - Disney ( DIS ) has sent a cease-and-desist letter to ByteDance accusing the Chinese company of using Disney ( DIS ) characters to train and power its Seedance 2.0 AI video generator without ​permission, a source familiar with the matter ‌told Reuters. Disney ( DIS ) said ByteDance had pre-packaged Seedance with a pirated library of...
Biocon aims for revenue surge with rollout of generic weight-loss drugs
Biocon aims for revenue surge with rollout of generic weight-loss drugs
Mar 11, 2026
By Rishika Sadam Feb 16 (Reuters) - Biocon is aiming for high-double-digit percentage revenue growth as the Indian pharmaceutical firm prepares to launch generic versions of weight-loss drugs globally even as it remains ​cautious about an early rollout in the home market, ‌a top company executive told Reuters. The company is counting on demand for obesity medicines as it expands...
Form 8.3
Form 8.3
Mar 11, 2026
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Sand Grove Capital Management LLP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved